Eugene Rubin, MD, PhD
Professor of Psychiatry
Vice Chairman for Education
Education and Training
B.A.: Psychology, University of Rochester, Rochester, New York, 1971
Ph.D.: Pharmacology, Washington University School of Medicine, St. Louis, Missouri, 1977
M.D.: Washington University School of Medicine, St. Louis, Missouri, 1978
Residency: Psychiatry, Washington University School of Medicine, St. Louis, Missouri, 1978-1982
Chief Residency: Psychiatry, Washington University School of Medicine, St. Louis, Missouri, 1983-1984
Listed in Best Doctors in America, 1996-2000, 2001-2002, 2003-2004, 2009, 2010, 2011-2012, 2013, 2014
AOA, Washington University School of Medicine;
Distinguished Educator Award for House Staff Teaching, 2009, Washington University School of Medicine;
Washington University School of Medicine Alumni/Faculty Award, 2008;
Excellence in Teaching Award presented by the Graduating Residency Class of 2007;
Distinguished Life Fellow, American Psychiatric Association
Areas of Research Interests
As a clinical investigator associated with the Washington University Alzheimer's Disease Research Center, my areas of emphasis have included the psychopathology of dementia of the Alzheimer type (DAT) and the characterization of presymptomatic DAT and very mild DAT. I am also involved in studies of affective disorder in populations with co-morbid coronary heart disease.
As Vice-chair for Education and former Residency Director, I am interested in both consumer and professional education. Recently, I co-authored two books with Charles F. Zorumski, MD: Demystifying Psychiatry (2010) and Psychiatry and Clinical Neuroscience: A Primer (2011).
Rubin EH, Zorumski CF. Perspective: Upcoming paradigm shifts for psychiatry in clinical care, research, and education. Acad Med. 2012;87(3): 261-5. Full Article ->
Zorumski CF, Rubin EH. Psychiatry and Clinical Neuroscience: A Primer. New York: Oxford University Press, 2011.
Zorumski CF, Rubin EH. Demystifying Psychiatry: A Resource for Patients and Families. New York: Oxford University Press, 2010.
Carney RM, Freedland KE, Stein PK, Steinmeyer BC, Harris WS, Rubin EH, Krone RJ, Rich MW. The effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease. Psychosom Med 2010;72:748-754.
Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. Omega-3 augmentation of sertraline in the treatment of depression in patients with coronary heart disease: a randomized controlled study. JAMA 2009;302:1651-1657.
Freedland KE, Skala JA, Carney RM, Rubin EH, Lustman PJ, Dávila-Román VG, Steinmeyer BC, Hogue CW Jr. Treatment of depression after coronary bypass surgery: a randomized controlled trial. Arch Gen Psychiatry 2009;66:387-396.
Funded Research Projects
NIA(Key Personnel):Healthy Aging & Senile Dementia - Core A: Clinical
NHLBI(Key Personnel):Omega-3 for Depression and Other Cardiac Risk Factors
NHLBI(Key Personnel):Cardiac Risk Markers and Unremitting Depression in Acute Coronary Syndrome
NIA(Key Personnel):Dominantly Inherited Alzheimer Network
NIA(Key Personnel):Alzheimers Disease Research Center - Clinical Core
AHRQ(Key Personnel):Randomized Controlled Trial of Screening for Depression in Cardiac Outpatients